{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T03:13:03Z","timestamp":1793502783327,"version":"4.5.0"},"reference-count":255,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jaci.2025.03.025","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T09:41:38Z","timestamp":1744105298000},"page":"503-522","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Personalized therapeutic approaches for asthma"],"prefix":"10.1016","volume":"156","author":[{"given":"Ioana","family":"Agache","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian M.","family":"Adcock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Baraldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kian Fan","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibon","family":"Eguiluz-Gracia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian L.","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Jutel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parameswaran","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Papi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celeste","family":"Porsbjerg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar S.","family":"Usmani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah A.","family":"Meyers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Zemelka-Wiacek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene R.","family":"Bleecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2025.03.025_bib1","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.jaci.2021.10.001","article-title":"Advances in asthma: new understandings of asthma\u2019s natural history, risk factors, underlying mechanisms, and clinical management","volume":"148","author":"Miller","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.03.025_bib2","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/S0140-6736(17)33311-1","article-title":"Asthma","volume":"391","author":"Papi","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2025.03.025_bib3","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/S0140-6736(22)02125-0","article-title":"Asthma","volume":"401","author":"Porsbjerg","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2025.03.025_bib4","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.jaci.2020.10.003","article-title":"2020 focused updates to the asthma management guidelines: a report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group","volume":"146","author":"Cloutier","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.03.025_bib5","article-title":"European Respiratory Society guidelines for the diagnosis of asthma in adults","volume":"15","author":"Louis","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2025.03.025_bib6","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1111\/all.15054","article-title":"Advances and highlights in asthma in 2021","volume":"76","author":"Agache","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2025.03.025_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2019.101301","article-title":"Severe asthma phenotypes and endotypes","volume":"46","author":"Agache","year":"2019","journal-title":"Semin Immunol"},{"key":"10.1016\/j.jaci.2025.03.025_bib8","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.jaci.2024.01.024","article-title":"Update on asthma biology","volume":"153","author":"Georas","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.03.025_bib9","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1165\/rcmb.2024-0082WS","article-title":"Asthma pathogenesis: phenotypes, therapies, and gaps: summary of the Aspen Lung Conference 2023","volume":"71","author":"Sharma","year":"2024","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.jaci.2025.03.025_bib10","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1056\/NEJMe1806037","article-title":"New biologics for asthma","volume":"378","author":"Drazen","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2025.03.025_bib11","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1056\/NEJMoa1905560","article-title":"Step-up therapy in Black children and adults with poorly controlled asthma","volume":"381","author":"Wechsler","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2025.03.025_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2022.106863","article-title":"The burden of mild asthma: clinical burden and healthcare resource utilisation in the NOVELTY study","volume":"200","author":"Golam","year":"2022","journal-title":"Respir Med"},{"key":"10.1016\/j.jaci.2025.03.025_bib13","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1164\/rccm.200906-0896OC","article-title":"Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program","volume":"181","author":"Moore","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2025.03.025_bib14","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/all.13985","article-title":"Mechanisms and therapeutic strategies for non-T2 asthma","volume":"75","author":"Sze","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2025.03.025_bib15","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1164\/rccm.201611-2232PP","article-title":"Eosinophilic and noneosinophilic asthma","volume":"197","author":"Carr","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2025.03.025_bib16","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1172\/JCI124611","article-title":"Precision medicine and phenotypes, endotypes, genotypes, regiotypes, and theratypes of allergic diseases","volume":"129","author":"Agache","year":"2019","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2025.03.025_bib17","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/j.1398-9995.2012.02832.x","article-title":"Untangling asthma phenotypes and endotypes","volume":"67","author":"Agache","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2025.03.025_bib19","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa2203163","article-title":"Albuterol\u2013budesonide fixed-dose combination rescue inhaler for asthma","volume":"386","author":"Papi","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2025.03.025_bib20","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1056\/NEJMoa063861","article-title":"Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma","volume":"356","author":"Papi","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2025.03.025_bib21","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1080\/17476348.2023.2247973","article-title":"Evaluating as-needed inhaled corticosteroid strategies in asthma: expanding the benefits to mild asthma","volume":"17","author":"Bigoni","year":"2023","journal-title":"Expert Rev Respir Med"},{"key":"10.1016\/j.jaci.2025.03.025_bib22","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00047-2023","article-title":"European Respiratory Society short guidelines for the use of as-needed ICS\/formoterol in mild asthma","volume":"62","author":"Papi","year":"2023","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2025.03.025_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaci.2019.05.031","article-title":"Phenotypes and endotypes of adult asthma: moving toward precision medicine","volume":"144","author":"Kaur","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.03.025_bib24","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1183\/13993003.00779-2015","article-title":"Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort","volume":"46","author":"Shaw","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2025.03.025_bib25","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/S2213-2600(16)30048-0","article-title":"Plasma interleukin-6 concentrations, metabolic dysfunction, and asthma severity: a cross-sectional analysis of two cohorts","volume":"4","author":"Peters","year":"2016","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaci.2025.03.025_bib26","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.jaci.2019.08.031","article-title":"Investigation of the relationship between IL-6 and type 2 biomarkers in patients with severe asthma","volume":"145","author":"Li","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.03.025_bib27","first-page":"167","volume":"2019","author":"Meyers","year":"2019"},{"key":"10.1016\/j.jaci.2025.03.025_bib28","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1164\/rccm.202009-3713OC","article-title":"Mixed sputum granulocyte longitudinal impact on lung function in the Severe Asthma Research Program","volume":"203","author":"Hastie","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2025.03.025_bib29","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jaci.2020.01.039","article-title":"Baseline sputum eosinophil + neutrophil subgroups\u2019 clinical characteristics and longitudinal trajectories for NHLBI Severe Asthma Research Program (SARP 3) cohort","volume":"146","author":"Hastie","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.03.025_bib30","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S2213-2600(24)00250-9","article-title":"Development of an asthma health-care burden score as a measure of severity and predictor of remission in SARP III and U-BIOPRED: results from two major longitudinal asthma cohorts","volume":"13","author":"Zein","year":"2025","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaci.2025.03.025_bib31","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1164\/rccm.202208-1569OC","article-title":"Longitudinal asthma phenotypes from childhood to middle-age: a population-based cohort study","volume":"208","author":"Tan","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2025.03.025_bib32","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/ije\/dyac173","article-title":"Asthma inflammatory phenotypes on four continents: most asthma is non-eosinophilic","volume":"52","author":"Pembrey","year":"2023","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.jaci.2025.03.025_bib33","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.chest.2021.04.013","article-title":"Eosinophilic and noneosinophilic asthma: an expert consensus framework to characterize phenotypes in a global real-life severe asthma cohort","volume":"160","author":"Heaney","year":"2021","journal-title":"Chest"},{"key":"10.1016\/j.jaci.2025.03.025_bib34","doi-asserted-by":"crossref","first-page":"4353","DOI":"10.1016\/j.jaip.2021.07.056","article-title":"Asthma phenotyping in primary care: applying the International Severe Asthma Registry eosinophil phenotype algorithm across all asthma severities","volume":"9","author":"Kerkhof","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2025.03.025_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2024.03.023","article-title":"Utility of eosinophil peroxidase as a biomarker of eosinophilic inflammation in asthma","author":"Tang","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.03.025_bib36","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.alit.2015.12.006","article-title":"Persistently high exhaled nitric oxide and loss of lung function in controlled asthma","volume":"65","author":"Matsunaga","year":"2016","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaci.2025.03.025_bib37","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1164\/rccm.201607-1453OC","article-title":"Effects of age and disease severity on systemic corticosteroid responses in asthma","volume":"195","author":"Phipatanakul","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2025.03.025_bib38","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1111\/cea.12954","article-title":"Responsiveness to oral prednisolone in severe asthma is related to the degree of eosinophilic airway inflammation","volume":"47","author":"Sousa","year":"2017","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2025.03.025_bib39","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1136\/thoraxjnl-2021-217994","article-title":"Longitudinal changes in sputum and blood inflammatory mediators during FeNO suppression testing","volume":"77","author":"Couillard","year":"2022","journal-title":"Thorax"},{"key":"10.1016\/j.jaci.2025.03.025_bib40","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1016\/j.jaip.2024.04.026","article-title":"Multivariate cluster analyses to characterize asthma heterogeneity and benralizumab responsiveness","volume":"12","author":"Li","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2025.03.025_bib41","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jaad.2021.07.064","article-title":"Phenotypes of atopic dermatitis and the risk for subsequent asthma: a systematic review and meta-analysis","volume":"86","author":"Li","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2025.03.025_bib42","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1164\/rccm.200907-1101OC","article-title":"Beyond atopy: multiple patterns of sensitization in relation to asthma in a birth cohort study","volume":"181","author":"Simpson","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2025.03.025_bib43","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1111\/all.12134","article-title":"Multiple atopy phenotypes and their associations with asthma: similar findings from two birth cohorts","volume":"68","author":"Lazic","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2025.03.025_bib44","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1111\/all.16265","article-title":"Evaluation of dupilumab on the disease burden in children and adolescents with atopic dermatitis: a population-based cohort study","volume":"79","author":"Tsai","year":"2024","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2025.03.025_bib45","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.iac.2019.07.005","article-title":"Atopic dermatitis is a barrier issue, not an allergy issue","volume":"39","author":"Kraft","year":"2019","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaci.2025.03.025_bib46","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00512-2024","article-title":"Benralizumab for allergic asthma: a randomised, double-blind, placebo-controlled trial","volume":"64","author":"Gauvreau","year":"2024","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2025.03.025_bib47","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/978-3-031-32259-4_10","article-title":"Systems biology in asthma","volume":"1426","author":"Kermani","year":"2023","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.jaci.2025.03.025_bib48","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1111\/all.15376","article-title":"Airway remodelling rather than cellular infiltration characterizes both type 2 cytokine biomarker\u2013high and \u2013low severe asthma","volume":"77","author":"Khalfaoui","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2025.03.025_bib49","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1111\/all.16092","article-title":"Skin, gut, and lung barrier: physiological interface and target of intervention for preventing and treating allergic diseases","volume":"79","author":"Berni Canani","year":"2024","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2025.03.025_bib50","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01397-2023","article-title":"The airway epithelium: an orchestrator of inflammation, a key structural barrier and a therapeutic target in severe asthma","volume":"63","author":"Russell","year":"2024","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2025.03.025_bib51","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.4049\/jimmunol.0802923","article-title":"IL-6 is required for airway mucus production induced by inhaled fungal allergens","volume":"183","author":"Neveu","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2025.03.025_bib52","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.jaci.2014.05.010","article-title":"A thymic stromal lymphopoietin\u2013responsive dendritic cell subset mediates allergic responses in the upper airway mucosa","volume":"134","author":"Melum","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.03.025_bib53","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/cea.14367","article-title":"Combined exposure to the alarmins TSLP, IL-33 and IL-25 enhances mast cell\u2013dependent contractions of human bronchi","volume":"53","author":"Belikova","year":"2023","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2025.03.025_bib54","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20231236","article-title":"TL1A is an epithelial alarmin that cooperates with IL-33 for initiation of allergic airway inflammation","volume":"221","author":"Schmitt","year":"2024","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2025.03.025_bib55","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jaci.2017.09.022","article-title":"Eosinophils and eosinophil-associated diseases: an update","volume":"141","author":"O\u2019Sullivan","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.03.025_bib56","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/s41556-021-00762-2","article-title":"Eosinophil extracellular traps drive asthma progression through neuro-immune signals","volume":"23","author":"Lu","year":"2021","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.jaci.2025.03.025_bib57","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/all.13997","article-title":"Eosinophil extracellular traps activate type 2 innate lymphoid cells through stimulating airway epithelium in severe asthma","volume":"75","author":"Choi","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2025.03.025_bib58","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jaci.2017.02.038","article-title":"Type 2 innate lymphoid cells disrupt bronchial epithelial barrier integrity by targeting tight junctions through IL-13 in asthmatic patients","volume":"141","author":"Sugita","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.03.025_bib59","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nm734","article-title":"Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma","volume":"8","author":"Kuperman","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2025.03.025_bib60","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/all.12593","article-title":"IL-33 drives airway hyper-responsiveness through IL-13\u2013mediated mast cell: airway smooth muscle crosstalk","volume":"70","author":"Kaur","year":"2015","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2025.03.025_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2022.156091","article-title":"IL-4 and IL-13, not eosinophils, drive type 2 airway inflammation, remodeling and lung function decline","volume":"162","author":"Scott","year":"2023","journal-title":"Cytokine"},{"key":"10.1016\/j.jaci.2025.03.025_bib62","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1165\/rcmb.2006-0419OC","article-title":"Measurement of IL-13\u2013induced iNOS-derived gas phase nitric oxide in human bronchial epithelial cells","volume":"37","author":"Suresh","year":"2007","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.jaci.2025.03.025_bib63","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1111\/all.15292","article-title":"Sequential class switch recombination to IgE and allergen-induced accumulation of IgE+ plasmablasts occur in the nasal mucosa of local allergic rhinitis patients","volume":"77","author":"Testera-Montes","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2025.03.025_bib64","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1104609","article-title":"IgE+ plasmablasts predict the onset of clinical allergy","volume":"14","author":"Simonin","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2025.03.025_bib65","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.immuni.2012.10.016","article-title":"Conventional and monocyte-derived CD11b+ dendritic cells initiate and maintain T helper 2 cell\u2013mediated immunity to house dust mite allergen","volume":"38","author":"Plantinga","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2025.03.025_bib66","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1111\/all.12435","article-title":"Myeloid dendritic cells are primed in allergic asthma for thymic stromal lymphopoietin-mediated induction of Th2 and Th9 responses","volume":"69","author":"Froidure","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2025.03.025_bib67","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1016\/j.jaci.2017.08.020","article-title":"TH1 signatures are present in the lower airways of children with severe asthma, regardless of allergic status","volume":"141","author":"Wisniewski","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.03.025_bib68","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1016\/j.jaci.2016.08.032","article-title":"Mechanism of TH2\/TH17-predominant and neutrophilic TH2\/TH17-low subtypes of asthma","volume":"139","author":"Liu","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.03.025_bib69","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.anai.2022.07.027","article-title":"T-cell responses in asthma exacerbations","volume":"129","author":"Bryant","year":"2022","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2025.03.025_bib70","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1172\/JCI80911","article-title":"High IFN-\u03b3 and low SLPI mark severe asthma in mice and humans","volume":"125","author":"Raundhal","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2025.03.025_bib71","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.jaci.2009.02.024","article-title":"TH17-associated cytokines (IL-17A and IL-17F) in severe asthma","volume":"123","author":"Al-Ramli","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.03.025_bib72","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.jaci.2009.03.033","article-title":"IL-17\u2013producing T cells in lung immunity and inflammation","volume":"123","author":"Nembrini","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.03.025_bib73","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1007\/s10875-012-9828-3","article-title":"Glucocorticoid receptor-beta up-regulation and steroid resistance induction by IL-17 and IL-23 cytokine stimulation in peripheral mononuclear cells","volume":"33","author":"Vazquez-Tello","year":"2013","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2025.03.025_bib74","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1165\/rcmb.2023-0424OC","article-title":"Unconventional activation of IRE1 enhances Th17 responses and promotes airway neutrophilia","volume":"71","author":"Wu","year":"2024","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.jaci.2025.03.025_bib75","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.3389\/fimmu.2020.01724","article-title":"Contribution of IL-17 in steroid hyporesponsiveness in obese asthmatics through dysregulation of glucocorticoid receptors \u03b1 and \u03b2","volume":"11","author":"Al Heialy","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2025.03.025_bib76","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s10020-023-00702-w","article-title":"Leptin\/obR signaling exacerbates obesity-related neutrophilic airway inflammation through inflammatory M1 macrophages","volume":"29","author":"Wang","year":"2023","journal-title":"Mol Med"},{"key":"10.1016\/j.jaci.2025.03.025_bib77","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jaci.2021.12.765","article-title":"Recent advances in the immunopathogenesis of severe asthma","volume":"149","author":"Al Heialy","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.03.025_bib78","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.jaci.2020.03.037","article-title":"Human TH1 and TH2 cells targeting rhinovirus and allergen coordinately promote allergic asthma","volume":"146","author":"Muehling","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.03.025_bib79","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1056\/NEJMoa2030880","article-title":"Risankizumab in severe asthma\u2014a phase 2a, placebo-controlled trial","volume":"385","author":"Brightling","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2025.03.025_bib80","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.immuni.2021.12.014","article-title":"Interferon gamma constrains type 2 lymphocyte niche boundaries during mixed inflammation","volume":"55","author":"Cautivo","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2025.03.025_bib81","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jaci.2022.06.028","article-title":"Multidimensional endotyping using nasal proteomics predicts molecular phenotypes in the asthmatic airways","volume":"151","author":"Agache","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.03.025_bib82","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/j.jaci.2023.01.028","article-title":"Bronchial epithelial cell transcriptional responses to inhaled corticosteroids dictate severe asthmatic outcomes","volume":"151","author":"Ginebaugh","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.03.025_bib83","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3390\/jpm14030246","article-title":"Machine learning prediction of treatment response to inhaled corticosteroids in asthma","volume":"14","author":"Ong","year":"2024","journal-title":"J Pers Med"},{"key":"10.1016\/j.jaci.2025.03.025_bib84","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1111\/all.15667","article-title":"EAACI guidelines on environmental science in allergic diseases and asthma\u2014leveraging artificial intelligence and machine learning to develop a causality model in exposomics","volume":"78","author":"Shamji","year":"2023","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2025.03.025_bib85","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1111\/all.15889","article-title":"Nomenclature of allergic diseases and hypersensitivity reactions: adapted to modern needs: an EAACI position paper","volume":"78","author":"Jutel","year":"2023","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2025.03.025_bib86","doi-asserted-by":"crossref","first-page":"573","DOI":"10.7326\/0003-4819-154-9-201105030-00002","article-title":"Omalizumab in severe allergic asthma inadequately controlled with standard therapy: a randomized trial","volume":"154","author":"Hanania","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaci.2025.03.025_bib87","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJMoa1403291","article-title":"Oral glucocorticoid\u2013sparing effect of mepolizumab in eosinophilic asthma","volume":"371","author":"Bel","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2025.03.025_bib88","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1164\/rccm.201103-0396OC","article-title":"Reslizumab for poorly controlled, eosinophilic asthma: a randomized, placebo-controlled study","volume":"184","author":"Castro","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2025.03.025_bib89","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1056\/NEJMoa1703501","article-title":"Oral glucocorticoid\u2013sparing effect of benralizumab in severe asthma","volume":"376","author":"Nair","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2025.03.025_bib90","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1056\/NEJMoa1804093","article-title":"Efficacy and safety of dupilumab in glucocorticoid-dependent severe asthma","volume":"378","author":"Rabe","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2025.03.025_bib91","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1164\/rccm.202210-2005OC","article-title":"Efficacy of tezepelumab in severe, uncontrolled asthma: pooled analysis of the PATHWAY and NAVIGATOR clinical trials","volume":"208","author":"Corren","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2025.03.025_bib92","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1056\/NEJMra2032506","article-title":"Biologic therapies for severe asthma","volume":"386","author":"Brusselle","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2025.03.025_bib93","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/all.14425","article-title":"EAACI biologicals guidelines\u2014recommendations for severe asthma","volume":"76","author":"Agache","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2025.03.025_bib94","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S2213-2600(17)30344-2","article-title":"Predictors of enhanced response with benralizumab for patients with severe asthma: pooled analysis of the SIROCCO and CALIMA studies","volume":"6","author":"FitzGerald","year":"2018","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaci.2025.03.025_bib95","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00936-2018","article-title":"Baseline patient factors impact on the clinical efficacy of benralizumab for severe asthma","volume":"52","author":"Bleecker","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2025.03.025_bib96","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/j.jaip.2022.03.020","article-title":"Dupilumab efficacy in steroid-dependent severe asthma by baseline oral corticosteroid dose","volume":"10","author":"Domingo","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2025.03.025_bib97","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.jaip.2022.11.043","article-title":"Baseline FeNO independently predicts the dupilumab response in patients with moderate-to-severe asthma","volume":"11","author":"Pavord","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2025.03.025_bib98","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1164\/rccm.202306-1102LE","article-title":"Effects of dupilumab on mucus plugging and ventilation defects in patients with moderate-to-severe asthma: a randomized, double-blind, placebo-controlled trial","volume":"208","author":"Svenningsen","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2025.03.025_bib99","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1164\/rccm.202304-0700ED","article-title":"Is efficacy of tezepelumab independent of severe asthma phenotype?","volume":"208","author":"Brusselle","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2025.03.025_bib100","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1361891","article-title":"Association between pre-biologic T2-biomarker combinations and response to biologics in patients with severe asthma","volume":"15","author":"Porsbjerg","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2025.03.025_bib101","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1513\/AnnalsATS.202010-1249OC","article-title":"A comprehensive analysis of the stability of blood eosinophil levels","volume":"18","author":"Chipps","year":"2021","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.jaci.2025.03.025_bib102","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1016\/j.jaip.2023.02.020","article-title":"Clinical implications of longitudinal blood eosinophil counts in patients with severe asthma","volume":"11","author":"Bleecker","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2025.03.025_bib103","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202307451","article-title":"A rapid sputum-based lateral flow assay for airway eosinophilia using an RNA-cleaving DNAzyme selected for eosinophil peroxidase","volume":"62","author":"Ali","year":"2023","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.jaci.2025.03.025_bib104","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00303-2019","article-title":"A point-of-care neutrophil elastase activity assay identifies bronchiectasis severity, airway infection and risk of exacerbation","volume":"53","author":"Shoemark","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2025.03.025_bib105","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.1111\/all.15915","article-title":"Sputum alarmins delineate distinct T2 cytokine pathways and unique subtypes of patients with asthma","volume":"78","author":"Gautam","year":"2023","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2025.03.025_bib106","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1183\/09031936.00078812","article-title":"Application of \u2019omics technologies to biomarker discovery in inflammatory lung diseases","volume":"42","author":"Wheelock","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2025.03.025_bib107","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.jaci.2020.11.032","article-title":"AsthmaMap: an interactive knowledge repository for mechanisms of asthma","volume":"147","author":"Mazein","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.03.025_bib108","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1111\/cea.14220","article-title":"Airway autoimmunity, asthma exacerbations, and response to biologics","volume":"52","author":"Venegas Garrido","year":"2022","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2025.03.025_bib109","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.jaip.2022.12.046","article-title":"Incidence of anti-drug antibodies to monoclonal antibodies in asthma: a systematic review and meta-analysis","volume":"11","author":"Chen","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2025.03.025_bib110","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00442-2022","article-title":"Airway autoantibodies are determinants of asthma severity","volume":"60","author":"Salter","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2025.03.025_bib111","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02446-2021","article-title":"Impact of former smoking exposure on airway eosinophilic activation and autoimmunity in patients with severe asthma","volume":"60","author":"Klein","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2025.03.025_bib112","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00117-2020","article-title":"Suboptimal treatment response to anti\u2013IL-5 monoclonal antibodies in severe eosinophilic asthmatics with airway autoimmune phenomena","volume":"56","author":"Mukherjee","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2025.03.025_bib113","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1165\/rcmb.2013-0067OC","article-title":"Airway smooth muscle hyperproliferation is regulated by microRNA-221 in severe asthma","volume":"50","author":"Perry","year":"2014","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.jaci.2025.03.025_bib114","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1586\/17476348.1.2.209","article-title":"Should treatments for asthma be aimed at the airway smooth muscle?","volume":"1","author":"Chung","year":"2007","journal-title":"Expert Rev Respir Med"},{"key":"10.1016\/j.jaci.2025.03.025_bib115","doi-asserted-by":"crossref","first-page":"L1230","DOI":"10.1152\/ajplung.00014.2004","article-title":"Fractalkine\/CX3CL1 production by human airway smooth muscle cells: induction by IFN-gamma and TNF-alpha and regulation by TGF-beta and corticosteroids","volume":"287","author":"Sukkar","year":"2004","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.jaci.2025.03.025_bib116","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1513\/pats.200504-028SR","article-title":"The role of airway smooth muscle in the pathogenesis of airway wall remodeling in chronic obstructive pulmonary disease","volume":"2","author":"Chung","year":"2005","journal-title":"Proc Am Thorac Soc"},{"key":"10.1016\/j.jaci.2025.03.025_bib117","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.993406","article-title":"Airway smooth muscle function in asthma","volume":"13","author":"Xiong","year":"2022","journal-title":"Front Physiol"},{"key":"10.1016\/j.jaci.2025.03.025_bib118","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.3390\/biomedicines9091281","article-title":"The impact of monoclonal antibodies on airway smooth muscle contractility in asthma: a systematic review","volume":"9","author":"Calzetta","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.jaci.2025.03.025_bib119","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1164\/rccm.201402-0314OC","article-title":"Impaired nuclear translocation of the glucocorticoid receptor in corticosteroid-insensitive airway smooth muscle in severe asthma","volume":"191","author":"Chang","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2025.03.025_bib120","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1111\/all.15076","article-title":"Single inhaler triple therapy (SITT) in asthma: systematic review and practice implications","volume":"77","author":"Agusti","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2025.03.025_bib121","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.chest.2021.03.047","article-title":"Seven pillars of small airways disease in asthma and COPD: supporting opportunities for novel therapies","volume":"160","author":"Usmani","year":"2021","journal-title":"Chest"},{"key":"10.1016\/j.jaci.2025.03.025_bib122","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0091-6749(97)70193-3","article-title":"Inflammation of small airways in asthma","volume":"100","author":"Hamid","year":"1997","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.03.025_bib123","first-page":"1","article-title":"Techniques of assessing small airways dysfunction","volume":"17","author":"McNulty","year":"2014","journal-title":"Eur Clin Respir J"},{"key":"10.1016\/j.jaci.2025.03.025_bib124","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00558-2022","article-title":"Development of a tool to detect small airways dysfunction in asthma clinical practice","volume":"61","author":"Kocks","year":"2023","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2025.03.025_bib125","doi-asserted-by":"crossref","first-page":"376","DOI":"10.4168\/aair.2014.6.5.376","article-title":"Small airways dysfunction in asthma: evaluation and management to improve asthma control","volume":"6","author":"Usmani","year":"2014","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.jaci.2025.03.025_bib126","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1016\/j.jaip.2021.04.035","article-title":"Small airway dysfunction links asthma severity with physical activity and symptom control","volume":"9","author":"Abdo","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2025.03.025_bib127","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S2213-2600(21)00536-1","article-title":"The role of small airway dysfunction in asthma control and exacerbations: a longitudinal, observational analysis using data from the ATLANTIS study","volume":"10","author":"Kraft","year":"2022","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaci.2025.03.025_bib128","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1159\/000343629","article-title":"Treating the small airways","volume":"84","author":"Usmani","year":"2012","journal-title":"Respiration"},{"key":"10.1016\/j.jaci.2025.03.025_bib129","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1164\/rccm.200410-1414OC","article-title":"Regional lung deposition and bronchodilator response as a function of beta2-agonist particle size","volume":"172","author":"Usmani","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2025.03.025_bib130","doi-asserted-by":"crossref","first-page":"433","DOI":"10.18176\/jiaci.0686","article-title":"The importance of small airway dysfunction in asthma: the GEMA-FORUM III Task Force","volume":"31","author":"Plaza","year":"2021","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaci.2025.03.025_bib131","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.jaci.2024.02.011","article-title":"Airway hyperresponsiveness in asthma: the role of the epithelium","volume":"153","author":"Bradding","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.03.025_bib132","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.jaci.2023.11.915","article-title":"Airway hyperresponsiveness correlates with airway TSLP in asthma independent of eosinophilic inflammation","volume":"153","author":"Andreasson","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.03.025_bib133","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01619-2023","article-title":"Airway remodelling in asthma and the epithelium: on the edge of a new era","volume":"63","author":"Varricchi","year":"2024","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2025.03.025_bib134","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jaci.2019.12.006","article-title":"An expert consensus framework for asthma remission as a treatment goal","volume":"145","author":"Menzies-Gow","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.03.025_bib135","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/all.15609","article-title":"Sounding the alarmins\u2014The role of alarmin cytokines in asthma","volume":"78","author":"Gauvreau","year":"2023","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2025.03.025_bib136","article-title":"Anti-alarmins in asthma: targeting the airway epithelium with next-generation biologics","volume":"25","author":"Porsbjerg","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2025.03.025_bib137","doi-asserted-by":"crossref","first-page":"749","DOI":"10.2147\/JAA.S275039","article-title":"Targeting TSLP in asthma","volume":"15","author":"Parnes","year":"2022","journal-title":"J Asthma Allergy"},{"key":"10.1016\/j.jaci.2025.03.025_bib138","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0144-2022","article-title":"Targeting interleukin-33 and thymic stromal lymphopoietin pathways for novel pulmonary therapeutics in asthma and COPD","volume":"32","author":"Calderon","year":"2023","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.jaci.2025.03.025_bib139","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/s12931-020-01526-6","article-title":"NAVIGATOR: a phase 3 multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of tezepelumab in adults and adolescents with severe, uncontrolled asthma","volume":"21","author":"Menzies-Gow","year":"2020","journal-title":"Respir Res"},{"key":"10.1016\/j.jaci.2025.03.025_bib140","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1056\/NEJMoa2034975","article-title":"Tezepelumab in adults and adolescents with severe, uncontrolled asthma","volume":"384","author":"Menzies-Gow","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2025.03.025_bib141","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1056\/NEJMoa1402895","article-title":"Effects of an anti-TSLP antibody on allergen-induced asthmatic responses","volume":"370","author":"Gauvreau","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2025.03.025_bib142","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01296-2021","article-title":"The effect of tezepelumab on airway hyperresponsiveness to mannitol in asthma (UPSTREAM)","volume":"59","author":"Sverrild","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2025.03.025_bib143","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/S2213-2600(21)00226-5","article-title":"Effect of tezepelumab on airway inflammatory cells, remodelling, and hyperresponsiveness in patients with moderate-to-severe uncontrolled asthma (CASCADE): a double-blind, randomised, placebo-controlled, phase 2 trial","volume":"9","author":"Diver","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaci.2025.03.025_bib144","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2300135","article-title":"Tezepelumab and mucus plugs in patients with moderate-to-severe asthma","volume":"2","author":"Nordenmark","year":"2023","journal-title":"NEJM Evid"},{"key":"10.1016\/j.jaci.2025.03.025_bib145","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1056\/NEJMoa2024257","article-title":"Efficacy and safety of itepekimab in patients with moderate-to-severe asthma","volume":"385","author":"Wechsler","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2025.03.025_bib146","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jacig.2022.07.002","article-title":"IL-33 receptor inhibition in subjects with uncontrolled asthma: a randomized, placebo-controlled trial","volume":"1","author":"Crim","year":"2022","journal-title":"J Allergy Clin Immunol Glob"},{"key":"10.1016\/j.jaci.2025.03.025_bib147","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.jaci.2021.03.044","article-title":"Astegolimab (anti-ST2) efficacy and safety in adults with severe asthma: a randomized clinical trial","volume":"148","author":"Kelsen","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.03.025_bib148","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01193-2022","article-title":"Inhaled anti-TSLP antibody fragment, ecleralimab, blocks responses to allergen in mild asthma","volume":"61","author":"Gauvreau","year":"2023","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2025.03.025_bib149","doi-asserted-by":"crossref","first-page":"3900","DOI":"10.1038\/s41467-024-48034-5","article-title":"A common polymorphism in the intelectin-1 gene influences mucus plugging in severe asthma","volume":"15","author":"Everman","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaci.2025.03.025_bib150","article-title":"Persistent mucus plugs in proximal airways are consequential for airflow limitation in asthma","volume":"9","author":"Huang","year":"2024","journal-title":"JCI Insight"},{"key":"10.1016\/j.jaci.2025.03.025_bib151","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1172\/JCI95693","article-title":"Mucus plugs in patients with asthma linked to eosinophilia and airflow obstruction","volume":"128","author":"Dunican","year":"2018","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2025.03.025_bib152","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1164\/rccm.202110-2265OC","article-title":"Mucus plugs persist in asthma, and changes in mucus plugs associate with changes in airflow over time","volume":"205","author":"Tang","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2025.03.025_bib153","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.jaip.2021.12.024","article-title":"The prevalence of mucus plugging in severe eosinophilic asthma and its relationship to clinical efficacy of anti\u2013IL-5R treatment","volume":"10","author":"Hearn","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2025.03.025_bib154","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.chest.2023.02.009","article-title":"CT mucus score and 129Xe MRI ventilation defects after 2.5 years\u2019 anti\u2013IL-5R\u03b1 in eosinophilic asthma","volume":"164","author":"McIntosh","year":"2023","journal-title":"Chest"},{"key":"10.1016\/j.jaci.2025.03.025_bib155","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.alit.2024.03.001","article-title":"Eosinophil\u2013mucus interplay in severe asthma: implications for treatment with biologicals","volume":"73","author":"Venegas Garrido","year":"2024","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaci.2025.03.025_bib156","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1084\/jem.20041901","article-title":"Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus","volume":"201","author":"Wark","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2025.03.025_bib157","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/nm1462","article-title":"Role of deficient type III interferon-lambda production in asthma exacerbations","volume":"12","author":"Contoli","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2025.03.025_bib158","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/j.jaci.2012.03.044","article-title":"Rhinovirus 16-induced IFN-\u03b1 and IFN-\u03b2 are deficient in bronchoalveolar lavage cells in asthmatic patients","volume":"129","author":"Sykes","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.03.025_bib159","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jaci.2012.05.023","article-title":"Innate immune responses to rhinovirus are reduced by the high-affinity IgE receptor in allergic asthmatic children","volume":"130","author":"Durrani","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.03.025_bib160","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1164\/rccm.202010-3754OC","article-title":"Pulmonary innate lymphoid cell responses during rhinovirus-induced asthma exacerbations in vivo: a clinical trial","volume":"204","author":"Dhariwal","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2025.03.025_bib161","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1164\/rccm.201406-1039OC","article-title":"IL-33\u2013dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo","volume":"190","author":"Jackson","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2025.03.025_bib162","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/cea.13765","article-title":"INEXAS: a phase 2 randomized trial of on-demand inhaled interferon beta-1a in severe asthmatics","volume":"51","author":"McCrae","year":"2021","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2025.03.025_bib163","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1164\/rccm.201312-2235OC","article-title":"The effect of inhaled IFN-\u03b2 on worsening of asthma symptoms caused by viral infections. A randomized trial","volume":"190","author":"Djukanovi\u0107","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2025.03.025_bib164","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1136\/thoraxjnl-2021-217429","article-title":"Effect of CRTH2 antagonism on the response to experimental rhinovirus infection in asthma: a pilot randomised controlled trial","volume":"77","author":"Farne","year":"2022","journal-title":"Thorax"},{"key":"10.1016\/j.jaci.2025.03.025_bib165","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/all.12627","article-title":"Th2 cytokines impair innate immune responses to rhinovirus in respiratory epithelial cells","volume":"70","author":"Contoli","year":"2015","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2025.03.025_bib166","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jaci.2014.11.039","article-title":"Increased nuclear suppressor of cytokine signaling 1 in asthmatic bronchial epithelium suppresses rhinovirus induction of innate interferons","volume":"136","author":"Gielen","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.03.025_bib167","doi-asserted-by":"crossref","first-page":"5999","DOI":"10.4049\/jimmunol.0901194","article-title":"Counterregulation between the FcepsilonRI pathway and antiviral responses in human plasmacytoid dendritic cells","volume":"184","author":"Gill","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2025.03.025_bib168","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.jaci.2015.09.008","article-title":"Preseasonal treatment with either omalizumab or an inhaled corticosteroid boost to prevent fall asthma exacerbations","volume":"136","author":"Teach","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.03.025_bib169","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/j.jaci.2017.07.035","article-title":"Enhanced plasmacytoid dendritic cell antiviral responses after omalizumab","volume":"141","author":"Gill","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.03.025_bib170","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.jaci.2022.03.025","article-title":"Eosinophil-mediated suppression and anti\u2013IL-5 enhancement of plasmacytoid dendritic cell interferon responses in asthma","volume":"150","author":"Dill-McFarland","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.03.025_bib171","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1164\/rccm.202209-1708OC","article-title":"Allergen immunotherapy enhances airway epithelial antiviral immunity in patients with allergic asthma (VITAL study): a double-blind randomized controlled trial","volume":"207","author":"Woehlk","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2025.03.025_bib172","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.cell.2016.05.041","article-title":"From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites","volume":"165","author":"Koh","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.jaci.2025.03.025_bib173","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.jaci.2022.09.026","article-title":"Airway-delivered short-chain fatty acid acetate boosts antiviral immunity during rhinovirus infection","volume":"151","author":"Antunes","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.03.025_bib174","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S2213-2600(23)00187-X","article-title":"Cough and cough hypersensitivity as treatable traits of asthma","volume":"11","author":"Lai","year":"2023","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaci.2025.03.025_bib175","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00408-023-00664-0","article-title":"Mucus transpiration as the basis for chronic cough and cough hypersensitivity","volume":"202","author":"Edwards","year":"2024","journal-title":"Lung"},{"key":"10.1016\/j.jaci.2025.03.025_bib176","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/B978-0-323-91534-2.00013-8","article-title":"Neural control of the lower airways: role in cough and airway inflammatory disease","volume":"188","author":"Taylor-Clark","year":"2022","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.jaci.2025.03.025_bib177","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/9956078","article-title":"RSV promotes epithelial neuroendocrine phenotype differentiation through NODAL signaling pathway","volume":"2021","author":"Liu","year":"2021","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.jaci.2025.03.025_bib178","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01386-2019","article-title":"Neuropeptide regulation of secretion and inflammation in human airway gland serous cells","volume":"55","author":"McMahon","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2025.03.025_bib179","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ejphar.2005.12.066","article-title":"Extending the understanding of sensory neuropeptides","volume":"533","author":"De Swert","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jaci.2025.03.025_bib180","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ejphar.2018.03.017","article-title":"Bradykinin in asthma: modulation of airway inflammation and remodelling","volume":"827","author":"Ricciardolo","year":"2018","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jaci.2025.03.025_bib181","doi-asserted-by":"crossref","DOI":"10.1172\/JCI150951","article-title":"Bitter taste signaling in tracheal epithelial brush cells elicits innate immune responses to bacterial infection","volume":"132","author":"Hollenhorst","year":"2022","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2025.03.025_bib182","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1001\/jama.2023.26032","article-title":"Gefapixant for chronic cough","volume":"331","author":"Turner","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.jaci.2025.03.025_bib183","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jaci.2013.01.051","article-title":"Genome-wide association study identifies TH1 pathway genes associated with lung function in asthmatic patients","volume":"132","author":"Li","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.03.025_bib184","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/ng.3787","article-title":"Genome-wide association analyses for lung function and chronic obstructive pulmonary disease identify new loci and potential druggable targets","volume":"49","author":"Wain","year":"2017","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaci.2025.03.025_bib185","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s41588-017-0014-7","article-title":"Multiancestry association study identifies new asthma risk loci that colocalize with immune-cell enhancer marks","volume":"50","author":"Demenais","year":"2018","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaci.2025.03.025_bib186","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S2213-2600(19)30055-4","article-title":"Shared and distinct genetic risk factors for childhood-onset and adult-onset asthma: genome-wide and transcriptome-wide studies","volume":"7","author":"Pividori","year":"2019","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaci.2025.03.025_bib187","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S2213-2600(18)30389-8","article-title":"Moderate-to-severe asthma in individuals of European ancestry: a genome-wide association study","volume":"7","author":"Shrine","year":"2019","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaci.2025.03.025_bib188","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1038\/s41467-020-15649-3","article-title":"Genome-wide analysis highlights contribution of immune system pathways to the genetic architecture of asthma","volume":"11","author":"Han","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaci.2025.03.025_bib189","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1056\/NEJMoa0911353","article-title":"Genomewide association between GLCCI1 and response to glucocorticoid therapy in asthma","volume":"365","author":"Tantisira","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2025.03.025_bib190","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/S2213-2600(13)70289-3","article-title":"Effect of rare variants in ADRB2 on risk of severe exacerbations and symptom control during longacting \u03b2 agonist treatment in a multiethnic asthma population: a genetic study","volume":"2","author":"Ortega","year":"2014","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaci.2025.03.025_bib191","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1016\/j.jaci.2019.01.012","article-title":"ADRB2 p.Thr164Ile association with hospitalization depends upon asthma severity","volume":"143","author":"Condreay","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.03.025_bib192","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/S2352-4642(21)00268-6","article-title":"Pharmacogenetic studies of long-acting beta agonist and inhaled corticosteroid responsiveness in randomised controlled trials of individuals of African descent with asthma","volume":"5","author":"Ortega","year":"2021","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.jaci.2025.03.025_bib193","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.2217\/epi.15.53","article-title":"Epigenome-modifying tools in asthma","volume":"7","author":"Brook","year":"2015","journal-title":"Epigenomics"},{"key":"10.1016\/j.jaci.2025.03.025_bib194","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jaci.2024.06.010","article-title":"Precision medicine for asthma treatment: unlocking the potential of the epigenome and microbiome","volume":"155","author":"Perez-Garcia","year":"2025","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.03.025_bib195","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01280-2019","article-title":"Differential DNA methylation in bronchial biopsies between persistent asthma and asthma in remission","volume":"55","author":"Vermeulen","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2025.03.025_bib196","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1111\/all.15824","article-title":"Identification of extracellular vesicle microRNA signatures specifically linked to inflammatory and metabolic mechanisms in obesity-associated low type-2 asthma","volume":"78","author":"Alhamdan","year":"2023","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2025.03.025_bib197","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1136\/thorax-2023-220707","article-title":"Genetic and T2 biomarkers linked to the efficacy of HDM sublingual immunotherapy in asthma","volume":"79","author":"Hoof","year":"2024","journal-title":"Thorax"},{"key":"10.1016\/j.jaci.2025.03.025_bib198","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1164\/rccm.202308-1477LE","article-title":"Mepolizumab-induced changes in nasal methylome and transcriptome to predict response in asthma","volume":"209","author":"Rakkar","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2025.03.025_bib199","doi-asserted-by":"crossref","first-page":"130","DOI":"10.4168\/aair.2024.16.2.130","article-title":"Epigenetic approaches to identifying asthma endotypes","volume":"16","author":"Kelly","year":"2024","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.jaci.2025.03.025_bib200","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1111\/jcmm.17924","article-title":"Epigenetic histone modification by butyrate downregulates KIT and attenuates mast cell function","volume":"27","author":"Gudneppanavar","year":"2023","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.jaci.2025.03.025_bib201","doi-asserted-by":"crossref","DOI":"10.1016\/j.envpol.2022.119323","article-title":"Lung toxicity of particulates and gaseous pollutants using ex-vivo airway epithelial cell culture systems","volume":"305","author":"Lakhdar","year":"2022","journal-title":"Environ Pollut"},{"key":"10.1016\/j.jaci.2025.03.025_bib202","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.jaci.2021.10.011","article-title":"Climate change and global issues in allergy and immunology","volume":"148","author":"Pacheco","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.03.025_bib203","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1111\/all.15977","article-title":"Metabolic pathways in immune senescence and inflammaging: novel therapeutic strategy for chronic inflammatory lung diseases. An EAACI position paper from the Task Force for Immunopharmacology","volume":"79","author":"Roth-Walter","year":"2024","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2025.03.025_bib204","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.3389\/fimmu.2019.01610","article-title":"Transcriptional effects of ozone and impact on airway inflammation","volume":"10","author":"Mumby","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2025.03.025_bib205","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1111\/all.16041","article-title":"The impact of outdoor pollution and extreme temperatures on asthma-related outcomes: a systematic review for the EAACI guidelines on environmental science for allergic diseases and asthma","volume":"79","author":"Agache","year":"2024","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2025.03.025_bib206","doi-asserted-by":"crossref","first-page":"644","DOI":"10.3390\/toxics10110644","article-title":"Machine learning\u2013based analyses of the effects of various types of air pollutants on hospital visits by asthma patients","volume":"10","author":"Lee","year":"2022","journal-title":"Toxics"},{"key":"10.1016\/j.jaci.2025.03.025_bib207","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2021.106435","article-title":"Short-term exposure to ozone, nitrogen dioxide, and sulphur dioxide and emergency department visits and hospital admissions due to asthma: a systematic review and meta-analysis","volume":"150","author":"Zheng","year":"2021","journal-title":"Environ Int"},{"key":"10.1016\/j.jaci.2025.03.025_bib208","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/s41390-023-02977-5","article-title":"Long-term PM2.5 exposure is associated with asthma prevalence and exhaled nitric oxide levels in children","volume":"97","author":"Tsai","year":"2025","journal-title":"Pediatr Res"},{"key":"10.1016\/j.jaci.2025.03.025_bib209","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.freeradbiomed.2022.04.011","article-title":"Stressed out\u2014the role of oxidative stress in airway smooth muscle dysfunction in asthma and COPD","volume":"185","author":"Saunders","year":"2022","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.jaci.2025.03.025_bib210","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1159\/000536578","article-title":"\u201cAir that once was breath\u201d part 1: wildfire-smoke\u2013induced mechanisms of airway inflammation. In Climate Change, Allergy and Immunology, Special IAAI Article Collection: Collegium Internationale Allergologicum Update, 2023","volume":"185","author":"Bowman","year":"2024","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2025.03.025_bib211","doi-asserted-by":"crossref","first-page":"879","DOI":"10.3390\/cells12060879","article-title":"The tobacco smoke component, acrolein, as a major culprit in lung diseases and respiratory cancers: molecular mechanisms of acrolein cytotoxic activity","volume":"12","author":"Hikisz","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.jaci.2025.03.025_bib212","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0020-2022","article-title":"The relationship of early-life household air pollution with childhood asthma and lung function","volume":"31","author":"Dai","year":"2022","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.jaci.2025.03.025_bib213","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1111\/all.16151","article-title":"The impact of exposure to tobacco smoke and e-cigarettes on asthma-related outcomes: systematic review informing the EAACI guidelines on environmental science for allergic diseases and asthma","volume":"79","author":"Agache","year":"2024","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2025.03.025_bib214","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1016\/j.jaip.2022.04.034","article-title":"Cigarette smoking and asthma","volume":"10","author":"Thomson","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2025.03.025_bib215","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02603-2021","article-title":"A multi-omics approach to delineate sputum microbiome-associated asthma inflammatory phenotypes","volume":"59","author":"Abdel-Aziz","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2025.03.025_bib216","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1164\/rccm.202211-2107OC","article-title":"Oropharyngeal microbiota clusters in children with asthma or wheeze associate with allergy, blood transcriptomic immune pathways, and exacerbation risk","volume":"208","author":"Abdel-Aziz","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2025.03.025_bib217","doi-asserted-by":"crossref","first-page":"e428","DOI":"10.1016\/S1473-3099(23)00692-8","article-title":"Global incidence and mortality of severe fungal disease","volume":"24","author":"Denning","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jaci.2025.03.025_bib218","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.alit.2023.08.004","article-title":"Relationship between Aspergillus and asthma","volume":"72","author":"Agarwal","year":"2023","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaci.2025.03.025_bib219","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1016\/j.jaip.2020.03.023","article-title":"Mepolizumab for allergic bronchopulmonary aspergillosis: report of 20 cases from the Belgian Severe Asthma Registry and review of the literature","volume":"8","author":"Schleich","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2025.03.025_bib220","first-page":"30510","article-title":"Functional effects of the microbiota in chronic respiratory disease","volume":"8","author":"Budden","year":"2019","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaci.2025.03.025_bib221","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1111\/all.15776","article-title":"Haemophilus influenzae and Moraxella catarrhalis in sputum of severe asthma with inflammasome and neutrophil activation","volume":"78","author":"Versi","year":"2023","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2025.03.025_bib222","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1080\/02770903.2023.2200844","article-title":"A narrative review on asthma and pest sensitization (cockroach, mouse and rat allergens): a social issue besides the medical problem","volume":"60","author":"Liccardi","year":"2023","journal-title":"J Asthma"},{"key":"10.1016\/j.jaci.2025.03.025_bib223","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.anai.2022.02.009","article-title":"Update on indoor allergens and their impact on pediatric asthma","volume":"128","author":"Maciag","year":"2022","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2025.03.025_bib224","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.aller.2019.06.011","article-title":"Avoidance of allergens as an environmental method in the prevention of inhaled allergy symptoms","volume":"48","author":"Strzelczyk","year":"2020","journal-title":"Allergol Immunopathol (Madr)"},{"key":"10.1016\/j.jaci.2025.03.025_bib225","doi-asserted-by":"crossref","first-page":"6","DOI":"10.5414\/ALX02451E","article-title":"Allergen immunotherapy for allergic asthma","volume":"8","author":"Virchow","year":"2024","journal-title":"Allergol Select"},{"key":"10.1016\/j.jaci.2025.03.025_bib226","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.jaip.2024.04.034","article-title":"Allergen immunotherapy: the evidence supporting the efficacy and safety of subcutaneous immunotherapy and sublingual forms of immunotherapy for allergic rhinitis\/conjunctivitis and asthma","volume":"12","author":"Creticos","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2025.03.025_bib227","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1001\/jama.2016.3964","article-title":"Efficacy of a house dust mite sublingual allergen immunotherapy tablet in adults with allergic asthma: a randomized clinical trial","volume":"315","author":"Virchow","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jaci.2025.03.025_bib228","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.2217\/imt-2018-0087","article-title":"Efficacy and tolerability of a house dust mite allergoid in allergic bronchial asthma: a randomized dose-ranging trial","volume":"10","author":"Jutel","year":"2018","journal-title":"Immunotherapy"},{"key":"10.1016\/j.jaci.2025.03.025_bib229","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.rmed.2019.06.003","article-title":"Age- and gender-specific incidence of new asthma diagnosis from childhood to late adulthood","volume":"154","author":"Honkam\u00e4ki","year":"2019","journal-title":"Respir Med"},{"key":"10.1016\/j.jaci.2025.03.025_bib230","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jaip.2023.11.031","article-title":"Allergen immunotherapy for asthma","volume":"12","author":"Kappen","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2025.03.025_bib231","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/all.13749","article-title":"EAACI guidelines on allergen immunotherapy: house dust mite\u2013driven allergic asthma","volume":"74","author":"Agache","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2025.03.025_bib232","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.jaci.2022.01.016","article-title":"Diverse immune mechanisms of allergen immunotherapy for allergic rhinitis with and without asthma","volume":"149","author":"Shamji","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.03.025_bib233","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.jaci.2022.10.007","article-title":"Immunotherapy: state-of-the-art review of therapies and theratypes","volume":"150","author":"Agache","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.03.025_bib234","doi-asserted-by":"crossref","first-page":"3584","DOI":"10.1111\/all.15506","article-title":"Real-world evidence for the long-term effect of allergen immunotherapy: current status on database-derived European studies","volume":"77","author":"Vogelberg","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2025.03.025_bib235","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1111\/all.16052","article-title":"House dust mite SCIT reduces asthma risk and significantly improves long-term rhinitis and asthma control\u2014a RWE study","volume":"79","author":"Jutel","year":"2024","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2025.03.025_bib236","article-title":"Impact of liquid sublingual immunotherapy on asthma onset and progression in patients with allergic rhinitis: a nationwide population-based study (EfficAPSI study)","volume":"41","author":"Demoly","year":"2024","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.jaci.2025.03.025_bib237","article-title":"Long-term real-world effectiveness of allergy immunotherapy in patients with allergic rhinitis and asthma: results from the REACT study, a retrospective cohort study","volume":"13","author":"Fritzsching","year":"2022","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.jaci.2025.03.025_bib238","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/all.14020","article-title":"The moderating role of allergy immunotherapy in asthma progression: results of a population-based cohort study","volume":"75","author":"Schmitt","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2025.03.025_bib239","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1111\/all.15321","article-title":"Cost-effectiveness analysis of house dust mite allergen immunotherapy in children with allergic asthma","volume":"77","author":"Farraia","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2025.03.025_bib240","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1111\/all.14723","article-title":"Cost-effectiveness of the subcutaneous house dust mite allergen immunotherapy plus pharmacotherapy for allergic asthma: a mathematical model","volume":"76","author":"Parra-Padilla","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2025.03.025_bib241","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1111\/all.15817","article-title":"Standardization of clinical outcomes used in allergen immunotherapy in allergic asthma: an EAACI position paper","volume":"78","author":"Kappen","year":"2023","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2025.03.025_bib242","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02474-2022","article-title":"Severe asthma trajectories in adults: findings from the NORDSTAR cohort","volume":"62","author":"von B\u00fclow","year":"2023","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2025.03.025_bib243","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jaci.2022.01.011","article-title":"Which patients with asthma are most likely to benefit from allergen immunotherapy?","volume":"149","author":"de Blay","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.03.025_bib244","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00819-2023","article-title":"Clinical remission in severe asthma with biologic therapy: an analysis from the UK Severe Asthma Registry","volume":"62","author":"McDowell","year":"2023","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2025.03.025_bib245","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1164\/rccm.202311-2192OC","article-title":"Exploring definitions and predictors of severe asthma clinical remission after biologic treatment in adults","volume":"210","author":"Perez-de-Llano","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2025.03.025_bib246","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1111\/all.16178","article-title":"Real-world biologics response and super-response in the International Severe Asthma Registry cohort","volume":"79","author":"Denton","year":"2024","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2025.03.025_bib247","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S2213-2600(24)00293-5","article-title":"Clinical remission attainment, definitions, and correlates among patients with severe asthma treated with biologics: a systematic review and meta-analysis","volume":"13","author":"Shackleford","year":"2025","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaci.2025.03.025_bib248","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S2213-2600(24)00304-7","article-title":"Asthma remission: a call for a globally standardised definition","volume":"13","author":"Lommatzsch","year":"2025","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaci.2025.03.025_bib249","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0140-6736(22)01198-9","article-title":"Mepolizumab for urban children with exacerbation-prone eosinophilic asthma in the USA (MUPPITS-2): a randomised, double-blind, placebo-controlled, parallel-group trial","volume":"400","author":"Jackson","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2025.03.025_bib250","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1164\/rccm.202305-0808OC","article-title":"Association between T2-related comorbidities and effectiveness of biologics in severe asthma","volume":"209","author":"Wechsler","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2025.03.025_bib251","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jaci.2018.07.028","article-title":"Baseline IL-22 expression in patients with atopic dermatitis stratifies tissue responses to fezakinumab","volume":"143","author":"Brunner","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.03.025_bib252","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.jaci.2013.10.011","article-title":"Sputum neutrophil counts are associated with more severe asthma phenotypes using cluster analysis","volume":"133","author":"Moore","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.03.025_bib253","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1016\/j.jaci.2016.08.048","article-title":"U-BIOPRED clinical adult asthma clusters linked to a subset of sputum omics","volume":"139","author":"Lefaudeux","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.03.025_bib254","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1016\/j.jaip.2024.04.035","article-title":"Novel machine learning identifies 5 asthma phenotypes using cluster analysis of real-world data","volume":"12","author":"Wu","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2025.03.025_bib255","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1111\/all.15849","article-title":"Current state and prospects of artificial intelligence in allergy","volume":"78","author":"van Breugel","year":"2023","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2025.03.025_bib256","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S2213-2600(23)00415-0","article-title":"Pioneering a paradigm shift in asthma management: remission as a treatment goal","volume":"12","author":"Lommatzsch","year":"2024","journal-title":"Lancet Respir Med"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674925003756?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674925003756?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T09:35:11Z","timestamp":1778664911000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674925003756"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":255,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0091674925003756"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2025.03.025","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Personalized therapeutic approaches for asthma","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2025.03.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}